CMN-005 by CoImmune for Relapsed Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval

Certain clinical characteristics were negatively associated with achieving a response to biologic therapies in patients with psoriasis, a meta-analysis showed. Using data from 31 observational

Val­ne­va is ex­tend­ing an ex­ist­ing loan by an ad­di­tion­al $100 mil­lion in an­tic­i­pa­tion of com­mer­cial­iz­ing its chikun­gun­ya vac­cine if ap­proved lat­er this year and for